vendredi 31 août 2012

Press Review (September 1, 2012) – Revue de presse (1 septembre 2012)





Breast Cancer Drug Might Help Men on Prostate Cancer Therapy
Study found tamoxifen cut some side effects that could discourage men from seeking treatment.
In U.S. News & World Report

Breast Cancer Drug May Harm the Heart More Than Thought‎‎
Analysis finds increased risk of cardiac problems with Herceptin in real-world setting.
By Kathleen Doheny. In U.S. News & World Report

New prostate cancer study clouds PSA debate
A new study suggests men with advanced prostate cancer may live longer in the "PSA era" than they did before the screening test began to gain a foothold in the early 1990s.
By Frederik Joelving. In Reuters

What Do Cancer Patients Think About Exercise?‎‎ ‎‎
Exercise is encouraged for cancer patients -- even if they are going through treatments. But a small new study from the Mayo Clinic suggests that some cancer patients still aren't prioritizing physical fitness, and their oncologists aren't talking to them about it.
In Huffington Post

Exelixis says FDA drops panel talks on thyroid cancer drug‎
Exelixis Inc said U.S. regulators have dropped an advisory panel discussion on the marketing application for its experimental drug to treat a rare form of thyroid cancer, sending its shares up 6 percent after market.
In Reuters

Could a cancer drug potentially prevent learning disabilities in some kids?‎
A drug originally developed to stop cancerous tumors may hold the potential to prevent abnormal brain cell growth and learning disabilities in some children, if they can be diagnosed early enough, a new animal study suggests.
In Medical Xpress

Cancer gene family member functions key to cell adhesion and migration‎
The WTX gene is mutated in approximately 30 percent of Wilms tumors, a pediatric kidney cancer. Like many genes, WTX is part of a family. In this case, WTX has two related siblings, FAM123A and FAM123C. While cancer researchers are learning more of WTX and how its loss contributes to cancer formation, virtually nothing is known of FAM123C or FAM123A, the latter of which is a highly abundant protein within neurons, cells that receive and send messages from the body to the brain and back to the body
In Medical Xpress



Cancer : et si on le traitait à l’aide du VIH ?‎
Comment combattre le cancer, l’un des pires fléaux de l’humanité ? Des scientifiques suggèrent d’utiliser un autre de nos plus féroces ennemis : le VIH. Ou plus précisément l'une des protéines qui lui permet de se multiplier autant...
Dans Futura-Sciences

Cancer : une molécule découverte‎‎‎‎ ‎‎
Une molécule susceptible d'agir contre les métastases, par le biais d'un nouveau mécanisme, vient d'être identifiée par des chercheurs, mais il faudra encore plusieurs années avant d'espérer passer aux premiers tests cliniques, précisent-ils.
Dans Le Figaro

La prévention au coeur du Congrès mondial sur le cancer, à Montréal
Des spécialistes en provenance de plus de 120 pays participent au 22e Congrès mondial sur le cancer, qui s'est ouvert au Palais des congrès de Montréal lundi.
Radio-Canada.ca

Cancer : une nouvelle molécule porteuse d'espoir‎‎‎‎‎ ‎‎
Des travaux de plus de dix années ont permis de mettre à jour la molécule "Liminib" qui bloquerait la formation des métastases. Cette découverte donne de l'espoir aux patients cancéreux et pourrait, dans un premier temps, servir de traitement alternatif à la chimiothérapie d'ici quelques années.
Dans Maxisciences



Aucun commentaire:

Enregistrer un commentaire